NewKerala.com

Chinese Scientists Pinpoint Key Ebola Mutation That Boosted Outbreak Spread

Chinese researchers have identified a specific mutation in the Ebola virus, named GP-V75A, that significantly increased its infectivity during a major outbreak in the Democratic Republic of the Congo. The variant carrying this mutation rapidly replaced the original strain, and its rise closely mirrored the surge in case numbers. Laboratory experiments confirmed the mutation enhances the virus's ability to infect host cells and mice. The study also warns that this mutation may diminish the effectiveness of some existing therapeutic antibodies and drugs.

Key Points: Key Ebola Virus Mutation Identified by Chinese Researchers

  • Mutation GP-V75A enhanced infectivity
  • Variant replaced original strain in DRC outbreak
  • Mutation may reduce drug and antibody effectiveness
  • Real-time genomic surveillance is crucial
  • Findings based on 480 virus genomes
2 min read

Chinese scientists identify key Ebola virus mutation

Study reveals a crucial Ebola virus mutation that increased infectivity and may reduce drug effectiveness, highlighting need for genomic surveillance.

"This is not only able to warn of changes in transmission risk but also to prospectively assess the effectiveness of existing drugs and vaccines. - Professor Qian Jun"

Beijing, Jan 27

Chinese researchers have unveiled a crucial mutation in the Ebola virus that significantly enhanced its infectivity during a major outbreak, providing new insights for epidemic surveillance and drug development.

The study, published in the journal Cell, focused on the Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo (DRC) from 2018 to 2020, the second-largest in history, which caused over 3,000 infections and more than 2,000 deaths, Xinhua news agency reported.

"The research tells us that during major emerging infectious disease outbreaks, real-time genomic surveillance and evolutionary analysis of the pathogen are crucial," said Professor Qian Jun from Sun Yat-sen University.

"This is not only able to warn of changes in transmission risk but also to prospectively assess the effectiveness of existing drugs and vaccines, guiding us to preemptively adjust control strategies," Jun added.

A key question drove the research, namely, beyond the impact of local healthcare challenges, did viral evolution itself contribute to the Ebola outbreak's prolonged duration?

"We have long been aware that key viral mutations often act as invisible drivers accelerating transmission during major outbreaks. Having worked on Ebola for over a decade, we had to investigate whether similar patterns of mutation existed for this virus," said Jun, explaining the team's motivation.

In 2022, the team analysed 480 complete Ebola virus genomes and discovered that a variant carrying a specific mutation in the viral glycoprotein, named GP-V75A, had emerged early in the DRC epidemic.

This variant rapidly replaced the original strain, and its rising prevalence closely mirrored the surge in case numbers, suggesting it might confer a transmission advantage, according to the research team.

Subsequent experiments using various models confirmed the mutation's biological impact. It showed that GP-V75A had significantly enhanced the virus's ability to infect multiple types of host cells and mice.

Furthermore, this study revealed a potential clinical concern, notably that the GP-V75A mutation had diminished the antiviral effectiveness of some existing therapeutic antibodies and small-molecule entry inhibitors, indicating a possible risk of drug resistance.

These findings underscore the importance of continuous viral genome monitoring during outbreaks to anticipate evolutionary threats and inform the development of broad-spectrum countermeasures, the research team said.

- IANS

Share this article:

Reader Comments

R
Rohit P
Important discovery, but let's be honest. The article is from Xinhua, China's state news agency. While the science might be solid, we must view such reports with a critical eye given the geopolitical context. I'd like to see this study validated by independent Western or Indian virologists. 🇮🇳
A
Aditya G
The part about the mutation reducing drug effectiveness is alarming. Viruses evolving to beat our medicines is a scary race. India's pharmaceutical industry should take note and collaborate on developing next-generation, broad-spectrum antivirals. This is a global public health issue.
M
Meera T
Science knows no borders. This is valuable work that can help the world prepare better. We should appreciate the research regardless of where it comes from. Hope our ICMR and research institutes are also working on such frontier virology projects.
K
Karthik V
Over 2,000 deaths... tragic. The focus should always be on strengthening healthcare systems in vulnerable regions to contain outbreaks faster. Genomic studies are important, but so is on-ground medical infrastructure. Both are needed.
S
Sarah B
As someone who works in public health, this is a classic example of evolution in action. The virus found a more efficient way to spread. Continuous monitoring is not an option; it's a necessity. This data is gold for vaccine developers.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50